Advertisement
The PROcedure Rehearsal Studio(TM), introduced by Simbionix last year, isthe world's first patient specific system to enable clinicians to createpractice scenarios based on their patient's unique anatomy as reconstructedfrom CTA or MRA data.
Advertisement
Preliminary data from ongoing research by the European Virtual RealityEndovascular Research Team (EVEResT) suggests that patient-specific rehearsalmay enhance the performance of interventionalists in subsequent endovascularprocedures. The preliminary data also suggested that after rehearsal,endovascular surgery is carried out more rapidly with less use of contrastand fluoroscopy and to a higher qualitative standard, compared to thoseinterventions preceded by a generic warm-up case, or no warm-up at all.
Professor Nick Cheshire, Professor of Vascular Surgery at ImperialCollege remarks: "We are pleased to report on the strong correlation betweenthe virtual and real operation with regards to the angiography images,endovascular access and material used during the intervention. The RehearsalStudio was able to adequately predict the optimal material for the specificcase at hand. Further research into the PROcedure Rehearsal Studio(TM) isexpected to determine if this technology can indeed help to improve thetechnical skills of the interventionalist and tailor these skills to thechallenges of a specific patient. The preliminary results already demonstrateshorter procedure time with less use of contrast; the end goal of theapplication of this technique will of course be to enhance patient safety andoutcome."
Mr. Ran Bronstein, President and COO at Simbionix adds: "We are verypleased with the results of the research work conducted on our newest system.The PROcedure Rehearsal Studio(TM) is an innovative product that utilizes aunique technology which was developed following intensive R&D efforts. Basedon initial reactions, I believe it will change the way physicians practiceand perform today."
About Imperial College Londonthe EVEResT Research Group
The EVEResT research group, led by Professor N. Cheshire, is amulticenter collaboration between the Imperial College London in the U.K.,the University Hospital Ghent in Belgium (Prof. F. Vermassen) and theSheffield Vascular Institute in the U.K.(Prof. P. Gaines).
The research group is multidisciplinary in nature, consisting of vascularsurgeons, radiologists and cardiologists. Its main goal is to provide aplatform for research into medical simulation and to aid the process ofvalidation and implementation of endovascular simulation as both a training,credentialing and procedure rehearsal tool.
About Simbionix USA Corporation
Simbionix is the leader in the development and delivery of innovative andeffective virtual reality simulation products and solutions for clinicaleducation and training of medical professionals. The products are designed toaccelerate best-practice medical training, advance clinical performance, andimprove patient safety.
The Simbionix product line includes the ANGIO Mentor(TM) line forendovascular procedures, LAP Mentor(TM) line for laparoscopic surgicalprocedures, GI Mentor(TM) for upper and lower gastrointestinal procedures andthe URO Mentor(TM) for urological procedures. In addition, Simbionixdistributes the HystSim(TM) for hysteroscopic procedures. Each simulationplatform is a leading simulator in the relevant clinical area.
Simbionix simulation products have been validated in several scientificstudies and the company cooperates closely with both industry and leadingmedical institutions to develop the most advanced simulators for the trainingand assessment of medical professionals.Galia Zilbershtein-Salant Exhibition Manager Simbionix Tel: +972-8-9211177 [email protected]
SOURCE Simbionix Ltd.
